These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 6792625

  • 21. [Microbiological research on fluid obtained during bronchoalveolar lavage of patients with circumscribed pulmonary tuberculosis].
    Karachunskiĭ MA, Dorozhkova IR, Gamzaeva NF.
    Probl Tuberk; 1988; (3):17-9. PubMed ID: 3133650
    [No Abstract] [Full Text] [Related]

  • 22. [Isolation of mycobacteria L forms as a prognostic criterion of recurrence and aggravation of tuberculosis in patients with extended residual tuberculous lesions of the lungs].
    Dorozhkova IR, Karachunskiĭ MA, Abdullaeva ET, Gamzaeva NF, Kochetkova EIa.
    Probl Tuberk; 1989; (3):14-8. PubMed ID: 2498865
    [Abstract] [Full Text] [Related]

  • 23. [Endogenous reactivation of tuberculosis as a result of reversion of persistent mycobacterial L-forms].
    Dorozhkova IR, Zemskova ZS, Krudu VN, Kochetkova EIa.
    Probl Tuberk; 1995; (3):43-6. PubMed ID: 7617636
    [Abstract] [Full Text] [Related]

  • 24. [Role of bacteriological research in the the expertise of the work capacity of patients with respiratory organ tuberculosis].
    Gavrilenko AF, Beliakova OI, Khoma OA.
    Probl Tuberk; 1985; (8):12-5. PubMed ID: 3932997
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical picture and course of newly detected pulmonary tuberculosis in elderly and senile patients, discharging L-forms of Mycobacterium tuberculosis].
    Kochetkova EIa.
    Probl Tuberk; 1989; (7):29-32. PubMed ID: 2508081
    [Abstract] [Full Text] [Related]

  • 26. [Characteristics of bacterial discharge in patients with different forms of pulmonary tuberculosis].
    Golanov VS, Andreev LP, Bogdalova VE, Meshcheriakov VG, Ushakova AG, Bondin SV.
    Probl Tuberk; 1994; (5):43-5. PubMed ID: 7870727
    [Abstract] [Full Text] [Related]

  • 27. [Quantitative and qualitative characteristics of bacterial excretion in socially maladapted patients with pulmonary tuberculosis and outcomes of the process].
    Bondin SV.
    Probl Tuberk; 1992; (3-4):51-3. PubMed ID: 1528836
    [Abstract] [Full Text] [Related]

  • 28. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV, Pashkov IuN, Pospelov VV.
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]

  • 30. [Diagnostic significance of isolating Mycobacterium tuberculosis L forms in patients at the sanatorium stage of treatment].
    Samillo GK.
    Probl Tuberk; 1986 May; (9):28-30. PubMed ID: 3097631
    [No Abstract] [Full Text] [Related]

  • 31. [Microbiological methods of Mycobacterium tuberculosis isolation during intravenous administration of antibacterial aerosols].
    Nemsadze MN, Milovanova EV, Agkatsev TV.
    Probl Tuberk; 1979 Nov; (11):57-61. PubMed ID: 119222
    [No Abstract] [Full Text] [Related]

  • 32. [Characteristics of patients--chronic carriers of Mycobacterium tuberculosis in Poland 1984].
    Miller M.
    Pneumonol Pol; 1986 Jun; 54(6):222-6. PubMed ID: 3101043
    [No Abstract] [Full Text] [Related]

  • 33. [Prognostic value of isolation of L-forms of Mycobacterium tuberculosis].
    Golanov VS, Bukharin OV, Usviatsov BIa, Seliukova SA.
    Probl Tuberk; 2002 Jun; (11):44-6. PubMed ID: 12501800
    [Abstract] [Full Text] [Related]

  • 34. [Epidemiological risks of tuberculous infection foci in patients discharging L forms of Mycobacterium tuberculosis].
    Khomenko AG, Muratov VV.
    Probl Tuberk; 1993 Jun; (2):2-5. PubMed ID: 7984560
    [Abstract] [Full Text] [Related]

  • 35. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA.
    Scand J Respir Dis Suppl; 1968 Jun; 65():147-50. PubMed ID: 4978458
    [No Abstract] [Full Text] [Related]

  • 36. [L forms of Mycobacterium tuberculosis in chronic pleural empyema in tuberculosis patients].
    Bogush LK, Karachunskiĭ MA, Dorozhkova IR, Zhangireev AA, Abramov EL.
    Probl Tuberk; 1981 Dec; (12):19-23. PubMed ID: 6801644
    [No Abstract] [Full Text] [Related]

  • 37. [Persistance of the agent of tuberculosis in the body as an L-form and its damging effect].
    Shmelev NA, Dorozhkova IR, Zemskova ZS.
    Vestn Akad Med Nauk SSSR; 1976 Dec; (5):29-37. PubMed ID: 823731
    [No Abstract] [Full Text] [Related]

  • 38. [Clinico-anatomical and microbiological research on the residual changes following spontaneously cured tuberculosis].
    Solov'eva IP, Dorozhkova IR, Biron MG.
    Probl Tuberk; 1986 Dec; (8):58-61. PubMed ID: 3095824
    [No Abstract] [Full Text] [Related]

  • 39. [Estimation of the degree of risk of reactivation of residual tuberculous changes based on the status of mycobacterial population].
    Krudu VN, Dorozhkova IR.
    Probl Tuberk; 1992 Dec; (5-6):45-7. PubMed ID: 1409517
    [Abstract] [Full Text] [Related]

  • 40. [Therapeutic and diagnostic tactics in so-called non-bacillary caverns in the lungs].
    Dmitriev RM.
    Probl Tuberk; 1980 Dec; (12):21-5. PubMed ID: 6784115
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.